Kezar Life Sciences, Inc. (KZR): Nasdaq/NYSE listing notice — Kezar receives Nasdaq deficiency notice for bid price below $1.00

Kezar Life Sciences, Inc.

Received Nasdaq letter Dec 1, 2023; stock closed below $1.00 for 30 consecutive business days.
Company has 180 days, until May 29, 2024, to regain compliance.
Must close at $1.00+ for 10 consecutive business days to cure.
May qualify for additional 180-day period if transferred to Nasdaq Capital Market.
Company will monitor bid price and evaluate options, including reverse stock split.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Kezar Life Sciences, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1)

Exact text from the filing

December 1, 2023, Kezar Life Sciences, Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the bid price of the Company’s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq Listing Rule 5450(a)(1). The notification received has no immediate effect on the listing of the Company’s common stock on the Nasdaq Stock Market. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the C

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Kezar Life Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-067777

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.